Business
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announce Dura Medical as the Expected Initial Florida Acquisition for its Planned International Network of Interventional Psychiatry Clinics
Dura Medical, with initial clinics in Naples and Fort Myers, to anchor the HOPE network in FloridaDelivers a full range of precision psychiatry services,
About this update from Nrx Pharmaceuticals, Inc.
[{"type":"text","content":"Dura Medical, with initial clinics in Naples and Fort Myers, to anchor the HOPE network in FloridaDelivers a full range of precision psychiatry services, including Ketamine and Transcranial Magnetic Stimulation (TMS), to veteran and civilian residents of Florida Stephen Durand, founder of Dura, to serve as Director of Clinic Growth for HOPE in FloridaAcquisition expected to be immediately accretive to revenue and EBITDA for NRxMIAMI, Jan. 6, 2025 /PRNewswire/ -- HOPE Therapeutics, Inc., (\"HOPE,\" the \"Company\"), a wholly-owned subsidiary of NRx Pharmaceuticals, Inc. (\"NRx\") (Nasdaq: NRXP), today announced the planned acquisition of Dura Medical (Dura), under a non-binding Letter of Intent. Dura is expected to be the first Florida acquisition for HOPE and serve as a cornerstone for the Southeastern States. Dura is revenue generating and EBITDA positive with immediate expansion opportunity to Florida's East Coast and beyond.\n\n \n \n \n \n \n \n\n \nDura was founded in 2018 to offer a gold-standard, precision approach to treating mental health and chronic pain. The clinics were the first in Florida leverage the latest interventional psychiatry procedures, including Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), Spravato® and Stellate Ganglion Blocks, augmented by traditional psychiatry and therapy to provide a full continuum of care for people with depression, suicidality, PTSD, anxiety, and related disorders.\nAs a US Army Veteran, Mr. Durand and Dura Medical are proud to partner with the Veterans Affairs Community Cares Network (VA CCN) which ensures that military veterans have full access to treatment for suicidal depression, PTSD, and Traumatic Incident Reduction (TIR).\nIn conjunction with the planned acquisition, Mr. Durand has agreed to serve as HOPE's Director of Clinical Growth for Florida, helping drive expansion throughout the state. He will be joined by David Feifel, MD, PhD (ref) and NRx's Chief Strategy Officer, CAPT Dennis K. McBride, PhD (US Navy Ret., SES-4 National Defense University, Ret.) a Clinical Psychologist who most recently served in the Office of the Secretary of Defense retiring at a civilian 3 star rank and has led relevant initiatives within the Defense Advanced Research Projects Agency (DARPA).\n\"Dura Medical was founded with the mission to reduce suicide in our community ...